|Publisher||Public Library of Science (PLoS)|
These results indicate that the LAM-ELISA can determine LAM concentration in sputum, and sputum LAM measured by the assay may be used as a biomarker of bacterial load prior to and during TB treatment. Additional studies are needed to examine the predictive value of this novel biomarker on treatment outcomes.
Known Files and URLs
|application/pdf 1.5 MB ||
grouping other versions (eg, pre-print) and variants of this release